China Approves Pfizer's COVID-19 Oral Drugs For Conditional Use

China's drug regulator approved conditional use of Pfizer oral drugs (pills) for COVID-19, on February 12. With this, Pfizer's Paxlovid pill will now be eligible for people with mild COVID-19 symptoms, at higher risk of the disease including senior citizens and people with co-morbodities, reported a local media agency. Meanwhile, the Chinese Government asked Pfizer to continue their research over the oral drug for a general use approval, later.